Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Moodys
Harvard Business School
Colorcon
McKinsey

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Purepac Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PUREPAC PHARM, and what generic and branded alternatives to PUREPAC PHARM drugs are available?

PUREPAC PHARM has one hundred and thirty approved drugs.

There are two tentative approvals on PUREPAC PHARM drugs.

Summary for Purepac Pharm
US Patents:0
Tradenames:62
Ingredients:61
NDAs:130
Patent Litigation for Purepac Pharm: See patent lawsuits for Purepac Pharm

Drugs and US Patents for Purepac Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm HYDROCORTISONE hydrocortisone TABLET;ORAL 084247-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Purepac Pharm METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 080309-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Purepac Pharm DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 072110-001 Sep 8, 1988 DISCN No No   Start Trial   Start Trial
Purepac Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 080403-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Purepac Pharm GEMFIBROZIL gemfibrozil CAPSULE;ORAL 072929-001 Jan 29, 1993 DISCN No No   Start Trial   Start Trial
Purepac Pharm DIFLUNISAL diflunisal TABLET;ORAL 074285-001 May 7, 1996 DISCN No No   Start Trial   Start Trial
Purepac Pharm MEPROBAMATE meprobamate TABLET;ORAL 084804-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
McKesson
AstraZeneca
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.